{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T12:07:14Z","timestamp":1775218034829,"version":"3.50.1"},"reference-count":87,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["CNS2022-135327"],"award-info":[{"award-number":["CNS2022-135327"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jacl.2025.12.025","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:20:28Z","timestamp":1767745228000},"page":"639-655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma lipidomics in women with Alzheimer\u2019s disease: Exploring associations with ApoE genotype and cardiovascular risk"],"prefix":"10.1016","volume":"20","author":[{"given":"Laura","family":"Ferr\u00e9-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Pe\u00f1a-Bautista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes","family":"\u00c1lvarez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar","family":"Peret\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Garc\u00eda-Vall\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Raga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Roca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Baquero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Consuelo","family":"Ch\u00e1fer-Peric\u00e1s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2025.12.025_bib1","unstructured":"World Health Organization. Dementia;\u00a02022.\u00a0Accessed October 19, 2022. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia."},{"issue":"5","key":"10.1016\/j.jacl.2025.12.025_bib2","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1002\/alz.13809","article-title":"2024 Alzheimer's disease facts and figures","volume":"20","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jacl.2025.12.025_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1105620","article-title":"Sex and gender considerations in Alzheimer\u2019s disease: the Women\u2019s Brain Project contribution","volume":"15","author":"Castro-Aldrete","year":"2023","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"10.1016\/j.jacl.2025.12.025_bib4","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jalz.2013.10.005","article-title":"Gender and incidence of dementia in the Framingham Heart Study from mid-adult life","volume":"11","author":"Ch\u00eane","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.jacl.2025.12.025_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11398","article-title":"A two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II","volume":"7","author":"Matthews","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacl.2025.12.025_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/CLEP.S37929","article-title":"Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences","volume":"6","author":"Mielke","year":"2014","journal-title":"Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.jacl.2025.12.025_bib7","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3233\/JAD-180141","article-title":"Differences between women and men in incidence rates of dementia and Alzheimer\u2019s disease","volume":"64","author":"Beam","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.jacl.2025.12.025_bib8","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-022-00574-4","article-title":"ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies","volume":"17","author":"Raulin","year":"2022","journal-title":"Mol Neurodegener"},{"issue":"2","key":"10.1016\/j.jacl.2025.12.025_bib9","first-page":"262","article-title":"Apolipoprotein E, gender, and Alzheimer\u2019s disease: an overlooked, but potent and promising interaction","volume":"8","author":"Ungar","year":"2014","journal-title":"Brain Imaging\u00a0Behav"},{"issue":"3","key":"10.1016\/j.jacl.2025.12.025_bib10","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3233\/JAD-190524","article-title":"APOE genotype differentially modulates plasma lipids in healthy older individuals, with relevance to brain health","volume":"72","author":"Wong","year":"2019","journal-title":"J Alzheimers Dis"},{"issue":"24","key":"10.1016\/j.jacl.2025.12.025_bib11","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1073\/pnas.1705080114","article-title":"A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain\u2013domain interactions","volume":"114","author":"Frieden","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.jacl.2025.12.025_bib12","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3233\/JAD-160925","article-title":"The association between plasma ceramides and sphingomyelins and risk of Alzheimer\u2019s disease differs by sex and APOE in the Baltimore Longitudinal Study of Aging","volume":"60","author":"Mielke","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jacl.2025.12.025_bib13","series-title":"Sex Differences in Physiology","first-page":"145","article-title":"Sex and gender differences in body composition, lipid metabolism, and glucose regulation","author":"Ethun","year":"2016"},{"key":"10.1016\/j.jacl.2025.12.025_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2023.117270","article-title":"Sex differences in lipids: a life course approach","volume":"384","author":"Holven","year":"2023","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2025.12.025_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2014.00241","article-title":"Sex-specific differences in lipid and glucose metabolism","volume":"5","author":"Varlamov","year":"2015","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jacl.2025.12.025_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molmet.2018.05.008","article-title":"Sex differences in lipid and lipoprotein metabolism","volume":"15","author":"Palmisano","year":"2018","journal-title":"Mol Metab"},{"key":"10.1016\/j.jacl.2025.12.025_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.119213","article-title":"Lipid metabolism in women: a review","volume":"405","author":"van Oortmerssen","year":"2025","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2025.12.025_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2018.00010","article-title":"Neuronal lipid metabolism: multiple pathways driving functional outcomes in health and disease","volume":"11","author":"Tracey","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.jacl.2025.12.025_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.00598","article-title":"Involvement of lipids in Alzheimer\u2019s disease pathology and potential therapies","volume":"11","author":"Chew","year":"2020","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.jacl.2025.12.025_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010131","article-title":"Lipids as emerging biomarkers in neurodegenerative diseases","volume":"25","author":"Wei","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1\u20134","key":"10.1016\/j.jacl.2025.12.025_bib21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000535131","article-title":"Brain lipids and lipid droplet dysregulation in Alzheimer\u2019s disease and neuropsychiatric disorders","volume":"9","author":"Zhao","year":"2023","journal-title":"Complex Psychiatry"},{"issue":"4","key":"10.1016\/j.jacl.2025.12.025_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041505","article-title":"Lipids and Alzheimer\u2019s disease","volume":"21","author":"Kao","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacl.2025.12.025_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yclnex.2018.05.001","article-title":"Lipids: an insight into the neurodegenerative disorders","volume":"20","author":"Shamim","year":"2018","journal-title":"Clin Nutr Exp"},{"issue":"2","key":"10.1016\/j.jacl.2025.12.025_bib24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jalz.2016.08.003","article-title":"Association of blood lipids with Alzheimer\u2019s disease: a comprehensive lipidomics analysis","volume":"13","author":"Proitsi","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.jacl.2025.12.025_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-021-01362-2","article-title":"Plasma lipidome is dysregulated in Alzheimer\u2019s disease and is associated with disease risk genes","volume":"11","author":"Liu","year":"2021","journal-title":"Transl Psychiatry"},{"issue":"7","key":"10.1016\/j.jacl.2025.12.025_bib26","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1073\/pnas.0305799101","article-title":"Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer\u2019s disease","volume":"101","author":"Cutler","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.jacl.2025.12.025_bib27","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jalz.2017.01.008","article-title":"Dysregulation of lipids in Alzheimer\u2019s disease and their role as potential biomarkers","volume":"13","author":"Wong","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"7","key":"10.1016\/j.jacl.2025.12.025_bib28","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201584RR","article-title":"Lipidomic markers for the prediction of progression from mild cognitive impairment to Alzheimer\u2019s disease","volume":"37","author":"Li","year":"2023","journal-title":"FASEB J"},{"key":"10.1016\/j.jacl.2025.12.025_bib29","article-title":"Plasma lipids as biomarkers for Alzheimer\u2019s disease: a systematic review","volume":"12","author":"Agarwal","year":"2020","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.jacl.2025.12.025_bib30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/1567205014666170505101426","article-title":"Lipid biomarkers in Alzheimer\u2019s disease","volume":"15","author":"Zarrouk","year":"2018","journal-title":"Curr Alzheimer Res"},{"issue":"2","key":"10.1016\/j.jacl.2025.12.025_bib31","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2174\/1570159X18666200729093724","article-title":"The links between cardiovascular diseases and Alzheimer\u2019s disease","volume":"19","author":"Leszek","year":"2020","journal-title":"Curr Neuropharmacol"},{"issue":"21","key":"10.1016\/j.jacl.2025.12.025_bib32","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030780","article-title":"Cardiovascular disease and Alzheimer\u2019s disease: the heart\u2013brain axis","volume":"12","author":"Saeed","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.jacl.2025.12.025_bib33","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1194\/jlr.P119000473","article-title":"High density lipoprotein and its apolipoprotein-defined subspecies and risk of dementia","volume":"61","author":"Koch","year":"2020","journal-title":"J Lipid Res"},{"issue":"8","key":"10.1016\/j.jacl.2025.12.025_bib34","doi-asserted-by":"crossref","first-page":"e498","DOI":"10.1016\/S2666-7568(21)00150-1","article-title":"Blood cholesterol and risk of dementia in more than 1\u00b78 million people over two decades: a retrospective cohort study","volume":"2","author":"Iwagami","year":"2021","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.jacl.2025.12.025_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/2617970","article-title":"Alzheimer\u2019s disease and cardiovascular disease: a particular association","volume":"2020","author":"Tini","year":"2020","journal-title":"Cardiol Res Pract"},{"key":"10.1016\/j.jacl.2025.12.025_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.937056","article-title":"Cholesterol as a key player in amyloid \u03b2-mediated toxicity in Alzheimer\u2019s disease","volume":"15","author":"Rudajev","year":"2022","journal-title":"Front Mol Neurosci"},{"issue":"11","key":"10.1016\/j.jacl.2025.12.025_bib37","doi-asserted-by":"crossref","DOI":"10.1001\/archneurol.2011.242","article-title":"Cholesterol level and statin use in Alzheimer disease","volume":"68","author":"Shepardson","year":"2011","journal-title":"Arch Neurol"},{"issue":"12","key":"10.1016\/j.jacl.2025.12.025_bib38","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1212\/WNL.0b013e3181d6476a","article-title":"Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease","volume":"74","author":"Feldman","year":"2010","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jacl.2025.12.025_bib39","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2016.3783","article-title":"Sex and race differences in the association between statin use and the incidence of Alzheimer disease","volume":"74","author":"Zissimopoulos","year":"2017","journal-title":"JAMA Neurol"},{"issue":"8","key":"10.1016\/j.jacl.2025.12.025_bib40","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1177\/1533317514534953","article-title":"Antibodies against gangliosides in patients with dementia","volume":"29","author":"Hatzifilippou","year":"2014","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1016\/j.jacl.2025.12.025_bib41","first-page":"757","article-title":"Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention","volume":"5","author":"Mill\u00e1n","year":"2009","journal-title":"Vasc Health Risk Manag"},{"issue":"1","key":"10.1016\/j.jacl.2025.12.025_bib42","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-023-01203-y","article-title":"Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer\u2019s disease","volume":"15","author":"Pillai","year":"2023","journal-title":"Alzheimers Res Ther"},{"issue":"16","key":"10.1016\/j.jacl.2025.12.025_bib43","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.3390\/jcm13164735","article-title":"Insights from a 7-year dementia cohort (VALCODIS): ApoE genotype evaluation","volume":"13","author":"Baquero","year":"2024","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.jacl.2025.12.025_bib44","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.jacl.2025.12.025_bib45","article-title":"Brain areas lipidomics in female transgenic mouse model of Alzheimer\u2019s disease","volume":"14","author":"Ferr\u00e9-Gonz\u00e1lez","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jacl.2025.12.025_bib46","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-024-01549-x","article-title":"Plasma lipidomics in early APP\/PS1 female mouse model and its relationship with brain: is it affected by the estrous cycle?","volume":"16","author":"Ferr\u00e9-Gonz\u00e1lez","year":"2024","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"10.1016\/j.jacl.2025.12.025_bib47","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1021\/acs.analchem.8b03409","article-title":"LipidMS: an R package for lipid annotation in untargeted liquid chromatography-data independent acquisition-mass spectrometry lipidomics","volume":"91","author":"Alcoriza-Balaguer","year":"2019","journal-title":"Anal Chem"},{"key":"10.1016\/j.jacl.2025.12.025_bib48","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1093\/bioinformatics\/btac581","article-title":"LipidMS 3.0: an R-package and a web-based tool for LC-MS\/MS data processing and lipid annotation","volume":"38","author":"Alcoriza-Balaguer","year":"2022","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.jacl.2025.12.025_bib49","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.18632\/aging.101837","article-title":"Longitudinal plasma metabolomics of aging and sex","volume":"11","author":"Darst","year":"2019","journal-title":"Aging"},{"issue":"1","key":"10.1016\/j.jacl.2025.12.025_bib50","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3233\/JAD-191304","article-title":"Relationships between plasma lipids species, gender, risk factors, and Alzheimer's disease","volume":"76","author":"Lim","year":"2020","journal-title":"J Alzheimers Dis"},{"issue":"17","key":"10.1016\/j.jacl.2025.12.025_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11175030","article-title":"Plasma lipidomics approach in early and specific Alzheimer\u2019s disease diagnosis","volume":"11","author":"Pe\u00f1a-Bautista","year":"2022","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.jacl.2025.12.025_bib52","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/lipd.12293","article-title":"Lipidomic analysis of plasma from healthy men and women shows phospholipid class and molecular species differences between sexes","volume":"56","author":"West","year":"2021","journal-title":"Lipids"},{"issue":"10","key":"10.1016\/j.jacl.2025.12.025_bib53","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1002\/oby.23517","article-title":"BMI and lipidomic biomarkers with risk of gestational diabetes in pregnant women","volume":"30","author":"Wang","year":"2022","journal-title":"Obesity"},{"issue":"5","key":"10.1016\/j.jacl.2025.12.025_bib54","doi-asserted-by":"crossref","first-page":"e1987","DOI":"10.1210\/clinem\/dgab931","article-title":"Novel lipidomic signature associated with metabolic risk in women with and without polycystic ovary syndrome","volume":"107","author":"Mousa","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.jacl.2025.12.025_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110747","article-title":"Lipidomic assessment of plasma and placenta of women with early-onset preeclampsia","volume":"9","author":"Korkes","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jacl.2025.12.025_bib56","first-page":"103","article-title":"Marked gender differences in progression of mild cognitive impairment over 8 years","volume":"1","author":"Lin","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.jacl.2025.12.025_bib57","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1007\/s11357-023-01020-z","article-title":"Sex differences in the progression to Alzheimer\u2019s disease: a combination of functional and structural markers","volume":"46","author":"Fern\u00e1ndez","year":"2023","journal-title":"GeroScience"},{"key":"10.1016\/j.jacl.2025.12.025_bib58","article-title":"Serum metabolites differentiate amnestic mild cognitive impairment from healthy controls and predict early Alzheimer\u2019s disease via untargeted lipidomics analysis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Neurol"},{"issue":"6","key":"10.1016\/j.jacl.2025.12.025_bib59","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/febs.16344","article-title":"Lipid metabolism and Alzheimer\u2019s disease: clinical evidence, mechanistic link and therapeutic promise","volume":"290","author":"Yin","year":"2023","journal-title":"FEBS J"},{"issue":"2","key":"10.1016\/j.jacl.2025.12.025_bib60","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3233\/JAD-150336","article-title":"Targeted lipidomics of fontal cortex and plasma diacylglycerols (DAG) in mild cognitive impairment and Alzheimer\u2019s disease: validation of DAG accumulation early in the pathophysiology of Alzheimer\u2019s disease","volume":"48","author":"Wood","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"10.1016\/j.jacl.2025.12.025_bib61","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1017\/neu.2015.18","article-title":"Non-targeted lipidomics of CSF and frontal cortex grey and white matter in control, mild cognitive impairment, and Alzheimer\u2019s disease subjects","volume":"27","author":"Wood","year":"2015","journal-title":"Acta Neuropsychiatr"},{"issue":"1","key":"10.1016\/j.jacl.2025.12.025_bib62","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-025-00803-6","article-title":"Lipidome disruption in Alzheimer\u2019s disease brain: detection, pathological mechanisms, and therapeutic implications","volume":"20","author":"He","year":"2025","journal-title":"Mol Neurodegener"},{"issue":"5","key":"10.1016\/j.jacl.2025.12.025_bib63","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/gerona\/glab335","article-title":"Age- and sex-dependent changes of free circulating blood metabolite and lipid abundances, correlations, and ratios","volume":"77","author":"Di Cesare","year":"2022","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"10.1016\/j.jacl.2025.12.025_bib64","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/acel.12416","article-title":"Age-associated changes in long-chain fatty acid profile during healthy aging promote pro-inflammatory monocyte polarization via PPAR\u03b3","volume":"15","author":"Pararasa","year":"2016","journal-title":"Aging Cell"},{"issue":"4","key":"10.1016\/j.jacl.2025.12.025_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/cells10040880","article-title":"Advances in understanding of the role of lipid metabolism in aging","volume":"10","author":"Chung","year":"2021","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.jacl.2025.12.025_bib66","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13934","article-title":"The lipidomic correlates of epigenetic aging across the adult lifespan: a population-based study","volume":"22","author":"Liu","year":"2023","journal-title":"Aging Cell"},{"issue":"3","key":"10.1016\/j.jacl.2025.12.025_bib67","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3233\/JAD-201504","article-title":"Association of lipidomics signatures in blood with clinical progression in preclinical and prodromal Alzheimer\u2019s disease","volume":"85","author":"Sakr","year":"2022","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"10.1016\/j.jacl.2025.12.025_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/biom14111362","article-title":"Exploring the dynamic changes of brain lipids, lipid rafts, and lipid droplets in aging and Alzheimer\u2019s disease","volume":"14","author":"Cerasuolo","year":"2024","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.jacl.2025.12.025_bib69","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/febs.16344","article-title":"Lipid metabolism and Alzheimer\u2019s disease: clinical evidence, mechanistic link and therapeutic promise","volume":"290","author":"Yin","year":"2023","journal-title":"FEBS J"},{"issue":"2","key":"10.1016\/j.jacl.2025.12.025_bib70","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/2211-5463.13661","article-title":"Novel insights into brain lipid metabolism in Alzheimer\u2019s disease: oligodendrocytes and white matter abnormalities","volume":"14","author":"Kawade","year":"2024","journal-title":"FEBS Open Bio"},{"issue":"1","key":"10.1016\/j.jacl.2025.12.025_bib71","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neurobiolaging.2008.03.011","article-title":"Serum sphingomyelins and ceramides are early predictors of memory impairment","volume":"31","author":"Mielke","year":"2010","journal-title":"Neurobiol Aging"},{"issue":"10","key":"10.1016\/j.jacl.2025.12.025_bib72","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.3390\/ijms25105317","article-title":"Relationship between plasma lipid profile and cognitive status in early Alzheimer disease","volume":"25","author":"Pe\u00f1a-Bautista","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"22","key":"10.1016\/j.jacl.2025.12.025_bib73","article-title":"Mitochondrial fatty acid \u03b2-oxidation disorders: from disease to lipidomic studies\u2014a critical review","volume":"23","author":"Guerra","year":"2022","journal-title":"Int J Mol Sc"},{"issue":"1","key":"10.1016\/j.jacl.2025.12.025_bib74","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20150240","article-title":"Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studies","volume":"36","author":"Wajner","year":"2016","journal-title":"Biosci Rep"},{"issue":"18","key":"10.1016\/j.jacl.2025.12.025_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241813977","article-title":"The role of Acyl-CoA \u03b2-oxidation in brain metabolism and neurodegenerative diseases","volume":"24","author":"Szrok-Jurga","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.jacl.2025.12.025_bib76","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2174\/1570159X19666210517114016","article-title":"Mitochondrial dysfunction in Alzheimer\u2019s disease: opportunities for drug development","volume":"20","author":"Bhatia","year":"2022","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.jacl.2025.12.025_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/346783","article-title":"Ceramides in Alzheimer\u2019s disease: key mediators of neuronal apoptosis induced by oxidative stress and A \u03b2 accumulation","volume":"2015","author":"Jazvin\u0161\u0107ak Jembrek","year":"2015","journal-title":"Oxid Med Cell Longev"},{"issue":"7","key":"10.1016\/j.jacl.2025.12.025_bib78","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1212\/WNL.0b013e318264e380","article-title":"Serum ceramides increase the risk of Alzheimer disease","volume":"79","author":"Mielke","year":"2012","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jacl.2025.12.025_bib79","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1210\/jc.2014-4348","article-title":"Association of plasma ceramides and sphingomyelin with VLDL apoB-100 fractional catabolic rate before and after rosuvastatin treatment","volume":"100","author":"Ng","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jacl.2025.12.025_bib80","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1194\/jlr.R046094","article-title":"Diversity and function of membrane glycerophospholipids generated by the remodeling pathway in mammalian cells","volume":"55","author":"Hishikawa","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2025.12.025_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100079","article-title":"Endothelial ether lipids link the vasculature to blood pressure, behavior, and neurodegeneration","volume":"62","author":"Spears","year":"2021","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.jacl.2025.12.025_bib82","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3233\/JAD-171036","article-title":"Alterations in the plasma levels of specific choline phospholipids in Alzheimer\u2019s disease mimic accelerated aging","volume":"62","author":"Dorninger","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.jacl.2025.12.025_bib83","first-page":"416","article-title":"Lower brain and blood nutrient status in Alzheimer\u2019s disease: results from meta-analyses","author":"de Wilde","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.jacl.2025.12.025_bib84","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/jnc.15681","article-title":"Plasma high-density lipoprotein cargo is altered in Alzheimer\u2019s disease and is associated with regional brain volume","volume":"163","author":"Pedrini","year":"2022","journal-title":"J Neurochem"},{"issue":"11","key":"10.1016\/j.jacl.2025.12.025_bib85","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.2174\/1567205013666160401115127","article-title":"Alzheimer\u2019s disease genetic risk factor APOE-\u03b54 also affects normal brain function","volume":"13","author":"M. Di Battista","year":"2016","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"10.1016\/j.jacl.2025.12.025_bib86","article-title":"Phospholipid biomarkers of coronary heart disease","volume":"10","author":"Morita","year":"2024","journal-title":"J Pharm Heal Care Sci"},{"issue":"3","key":"10.1016\/j.jacl.2025.12.025_bib87","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/eurheartj\/ehz387","article-title":"Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients","volume":"41","author":"Hilvo","year":"2020","journal-title":"Eur Heart J"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425005628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425005628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T11:30:59Z","timestamp":1775215859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287425005628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":87,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1933287425005628"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2025.12.025","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma lipidomics in women with Alzheimer\u2019s disease: Exploring associations with ApoE genotype and cardiovascular risk","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2025.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 National Lipid Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}